CABRINI, Giulio
 Distribuzione geografica
Continente #
NA - Nord America 897
EU - Europa 293
AS - Asia 171
OC - Oceania 1
Totale 1.362
Nazione #
US - Stati Uniti d'America 897
IT - Italia 108
CN - Cina 85
HK - Hong Kong 48
PL - Polonia 42
BE - Belgio 32
SE - Svezia 32
TR - Turchia 27
DE - Germania 23
GB - Regno Unito 23
UA - Ucraina 21
VN - Vietnam 7
FI - Finlandia 6
FR - Francia 2
IR - Iran 2
MK - Macedonia 2
AU - Australia 1
IL - Israele 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 1.362
Città #
Fairfield 126
Woodbridge 110
Ashburn 104
Chandler 73
Houston 62
Ferrara 58
Hong Kong 48
Wilmington 48
Cambridge 46
Seattle 43
Warsaw 41
Ann Arbor 32
Brussels 31
Jacksonville 30
Beijing 25
Shanghai 22
Izmir 19
Addison 18
Princeton 17
Washington 11
Milan 10
Nanjing 10
Bremen 9
Dong Ket 7
San Diego 6
Boardman 5
Hebei 5
Mountain View 5
Dearborn 4
Ferrara di Monte Baldo 4
Jiaxing 4
Nanchang 4
Changsha 3
Chicago 3
Harvard 3
Jinan 3
London 3
Norwalk 3
Redwood City 3
Trieste 3
Venice 3
Auburn Hills 2
Augusta 2
Bacoli 2
Brindisi 2
Cesena 2
Chongqing 2
Des Moines 2
Groton 2
Guarda Veneta 2
Naples 2
Paris 2
Pescara 2
Tappahannock 2
Trento 2
Albuquerque 1
Ardabil 1
Bevagna 1
Bologna 1
Broomfield 1
Falls Church 1
Fremont 1
Guangzhou 1
Haikou 1
Helsinki 1
Hounslow 1
Jinhua 1
Kilburn 1
Leawood 1
Leuven 1
Lisbon 1
Los Angeles 1
Monmouth Junction 1
North Chelmsford 1
Parma 1
Perth 1
Redmond 1
Riyadh 1
Saint Louis 1
San Donà di Piave 1
Shenyang 1
Sindelfingen 1
Tianjin 1
Wandsworth 1
Wuhan 1
Totale 1.122
Nome #
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 162
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 141
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 130
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 130
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 125
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 99
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 91
A new method for measuring local ATP release at the extracellular surface of live intact cells 78
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 55
Mitochondrial Ca2+-dependent inflammasome activation exacerbates the P. aeruginosa-driven inflammatory response 47
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib 43
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis 42
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 36
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis 32
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 29
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 29
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 26
miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases 23
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 22
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 20
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 16
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 16
Overview of CF lung pathophysiology 15
Revealing the microRNA-transcription factors network in cystic fibrosis:from microRNA therapeutics to precision medicine (CF-miRNA-THER) FFC 7/2018 15
CFTR Modulators and Reduction of Airway Inflammation in Cystic Fibrosis: How Much is Enough? 12
Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators 3
Totale 1.437
Categoria #
all - tutte 6.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.814


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019105 0 0 0 0 0 0 0 0 10 24 27 44
2019/2020302 29 8 13 32 62 39 21 21 29 24 18 6
2020/2021272 13 5 9 16 12 22 40 29 20 40 34 32
2021/2022191 9 8 18 6 9 8 21 13 13 12 25 49
2022/2023219 21 34 4 19 26 14 25 17 20 1 27 11
2023/2024222 15 32 16 4 72 46 10 23 4 0 0 0
Totale 1.437